These results, along with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assistance the concept of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked disorders. It can also be https://douglasg305fwd6.ssnblog.com/profile